The punch from vaccine nationalism to poor countries

The punch from vaccine nationalism to poor countries 5

The punch from vaccine nationalism to poor countries

As the number of nCoV infections in the world increases again, vaccine nationalism in major manufacturers such as India or Europe also increases.

Vaccine `deep gap` between rich and poor countries

The plan to maintain domestic supplies of countries capable of producing vaccines is deepening the `record gap` between rich and poor countries, dealing another blow to the prospect of global cooperation against Covid-19, according to the General Assembly.

The world’s largest vaccine manufacturer, the Serum Institute of India, is the main source of Covax.

The initiative was threatened when India decided to cut some export shipments, keeping more vaccines for domestic use when there is a new outbreak.

A woman is injected with the Covid-19 vaccine produced by the Serum Institute of India at Max Super Specialty Hospital, in New Delhi, March 17.

Developing countries from Kenya to Brazil have had their distribution delayed, according to data from the Gavi Vaccine Alliance.

Data shows that most countries have received doses of Pfizer’s vaccine distributed by Covax.

The move from India reminds people of the EU’s controversial decision.

Fiona Russell, head of the Asia-Pacific health team at the Murdoch Children’s Research Institute, said hopes for vaccine equality were collapsing.

`We foresee that, because the vaccines are stuck in Europe, now India and the US. The supply to the rest of the world is not going anywhere. That is a big problem,` she said.

Vaccine diplomacy

In recent months, India has attempted to strengthen its global image through vaccine diplomacy, alongside China.

But after the country donated more than 60 million vaccine doses, the export process slowed down.

According to the Gavi Vaccine Alliance, India’s increased domestic vaccine demand is the reason why officials delayed granting an export license to the Serum Institute.

`Covax is negotiating with the government to ensure the fastest possible delivery,` a Gavi representative said.

The punch from vaccine nationalism to poor countries

Officials unload a box of AstraZeneca vaccine produced by the Serum Institute outside a storage warehouse in Ahmedabad, India, January 12.

The stance of focusing on domestic vaccine distribution is considered obvious in the world’s strongest economies.

Biden administration officials said that despite restricting vaccine exports, US companies are still required to complete contracts with other countries.

`Every government is accountable to its citizens,` said Jaspreet Pannu, a resident physician and global health and biosecurity researcher at Stanford University School of Medicine.

Vaccine scarcity

Since Ghana became the first country to receive 600,000 vaccine doses from Covax, the program has distributed more than 32 million other doses to 60 countries.

Bruce Aylward, a senior adviser to the WHO, pointed to the Serum Institute of India and AstraZeneca as those not providing enough vaccines.

Problems from Covax put developing countries, especially those that rely entirely on supplies from this initiative, in crisis and had to fight for contracts themselves.

The shortage occurs despite the fact that globally, supplies are relatively abundant.

`The need for equitable vaccine access is urgent,` said Andrea Taylor, head of Covid-19 research at Duke University’s Global Health Institute.

Post Comment